Jason Davis
Chief Financial Officer · FibroBiologics, Inc.
- 2026
- May 4, 2026
- 2
Summary
Latest filing:
Jason Davis is Chief Financial Officer of FibroBiologics, Inc. (FBLG). 2 SEC Form 4 filings on record, most recently on 4 May 2026. Most recent open-market trade: bought $29K of FBLG on 3 March 2026. Lifetime open-market purchases: $29K.
Recent transactions
1The latest SEC Form 4 transaction reported by Jason Davis.
Trading pattern
InsiderAlpha's records for Jason Davis go back to 2026: 2 primary Form 4 filings, an average of 2.0 per year. The typical open-market purchase is $29K (1 buy totaling $29K). The largest single buy on record is $29K of FBLG in 2026. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jason Davis files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ruben A. Garcia - $61K in FBLG purchases and sales in the last 12 months
- Pete O'Heeron - $20K in FBLG purchases and sales in the last 12 months
- Hamid Khoja - $11K in FBLG purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jason Davis?
Jason Davis is a corporate insider, tracked as Chief Financial Officer of FibroBiologics, Inc. (FBLG). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Jason Davis last file a Form 4?
The most recent primary Form 4 on record is dated 4 May 2026, one of 2 filings going back to 2026.
Has Jason Davis been buying or selling stock?
Recorded transactions: 1 open-market purchase ($29K) and 0 open-market sales across all tracked filings.